Selumetinib overcomes gefitinib primary and acquired resistance by regulating MIG6/STAT3 in NSCLC
Article in Archives of Pharmacal Research (November 2023)
The most recent citing publications are shown below. View all 51 publications that cite this research output on Dimensions.
Article in Archives of Pharmacal Research (November 2023)
Article in International Immunopharmacology (March 2023)
Book chapter (November 2022)